Actuate Therapeutics, Inc Common stock
Price & Volume
Stats
See more52W Range | $5.47-$11.99 |
Market Cap | $188M |
Shares Short | 614,517 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.11 |
News
See moreYahoo Finance • 20 days ago
Actuate Therapeutics Provides FDA with Updated Clinical Data Package to Support Planned Regulatory Interactions with FDA and EMA Over the Coming Months
Yahoo Finance • 30 days ago
Actuate Therapeutics Announces Closing of $17.25 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option
Yahoo Finance • last month
Sector Update: Health Care Stocks Retreat Late Afternoon
Yahoo Finance • last month
Actuate Therapeutics Announces Pricing of $15.0 Million Public Offering of Common Stock
About
CEO | Mr. Daniel M. Schmitt |
Address | 1751 River Run, Fort Worth, TX, United States, 76107 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 10 |
